Showing 981-990 of 1560 results for "".
- Potential New Target for Early Treatment of Alzheimer's Diseasehttps://reachmd.com/news/potential-new-target-for-early-treatment-of-alzheimers-disease/2467229/UNIVERSITY PARK, Pa. — A class of proteins that regulates cell repair and enhances cell growth-signaling systems could be a promising new target for the treatment of Alzheimer's and other neurodegenerative diseases, according to a new study led by researchers at Penn State. They fou
- Researchers Unravel Glucose-Sensing Mechanism That Controls Thermogenesishttps://reachmd.com/news/researchers-unravel-glucose-sensing-mechanism-that-controls-thermogenesis/2462670/Adipocytes, also known as fat cells, come in three main types: white, brown, and beige. White fat cells are structurally quite simple, comprising a single fat molecule and a few organelles. The function of white adipocytes is to store energy, in
- FDA Gives Nod to Marketing DermaSensor for Skin Lesion Evaluationhttps://reachmd.com/news/fda-gives-nod-to-dermasensor-for-skin-lesion-evaluation/2462213/The U.S Food and Drug Administration (FDA) announced that it has granted authorization for marketing for the DermaSensor (DermaSensor Inc.) prescription device, indicated for the evaluation of skin lesions suggestive of melanoma, basal cell carcinoma, and/or squamous cell carcinoma in patients ag
- Advancements in Breast Cancer Screening and Risk Prediction in Elderly Womenhttps://reachmd.com/news/advancements-in-breast-cancer-screening-and-risk-prediction-in-elderly-women/2483501/The management of breast cancer in elderly women presents ongoing challenges, stemming from the complex balance of screening benefits against potential risks. The growing body of research underscores the need for personalized screening and risk prediction strategies. Using validated
- Breaking New Ground in Sjögren’s Disease: The Success of Ianalumab Phase III Trialshttps://reachmd.com/news/breaking-new-ground-in-sjogrens-disease-the-success-of-ianalumab-phase-iii-trials/2476129/Recent developments, exemplified by the promising Phase III results of ianalumab, may signal a shift in the treatment landscape for Sjögren’s disease, although detailed peer‑reviewed data and regulatory review are still pending. In this context, symptoms like dry mouth and eyes stem
- Addressing Psychosocial Factors in Dermatological and Psychiatric Carehttps://reachmd.com/news/addressing-psychosocial-factors-in-dermatological-and-psychiatric-care/2475865/The psychosocial burden of conditions such as alopecia areata often stems more from patients’ illness perceptions and societal stigma than from hair loss severity, challenging clinicians to look beyond physical symptoms to address mental health needs. Clinicians traditionally focus o
- Unraveling the Impact of GDF3 Signaling in Age-Related Inflammationhttps://reachmd.com/news/unraveling-the-impact-of-gdf3-signaling-in-age-related-inflammation/2484949/University of Minnesota researchers show that macrophage-derived GDF3 sustains low-grade inflammation in older adults and increases vulnerability to infection, linking aged immune cell
- New Findings on Impacts of Anxiety and Insomnia on Immune Functionhttps://reachmd.com/news/anxiety-insomnia-immune-function/2484930/A recent cohort study found lower circulating natural killer (NK) cell counts and altered NK subtypes in young female students reporting a
- Advances in Immune-Mediated Therapies for Intestinal Regenerationhttps://reachmd.com/news/advances-in-immune-mediated-therapies-for-intestinal-regeneration/2484896/CAR T-cell therapy shows rapid epithelial regeneration and reduced inflammation in preclinical aging and radiation models. In adoptive-transfer experiments, en
- CEMIP: Unraveling Its Role in Myelin Damage and Neurodegenerationhttps://reachmd.com/news/cemip-unraveling-its-role-in-myelin-damage-and-neurodegeneration/2484894/CEMIP (Cell Migration Inducing and Hyaluronan-binding Protein) is now framed as an enzymatic driver of myelin damage, with direct relevance to multiple sclerosis and related neurodegenerative disorders.